Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px

News > All

Total search results: 12000 | Ordered by Date (descending)
1 2 3 ... 119 120 121  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London. 2019-07-16
Immunic, Inc.. (7/16/19). "Press Release: Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer". San Diego, CA. 2019-07-16
Novartis AG. (7/16/19). "Press Release: FDA Accepts File and Accelerates Review of Novartis Sickle Cell Disease Medicine Crizanlizumab (SEG101)". Basel. 2019-07-16
Recursion Pharmaceuticals, Inc.. (7/15/19). "Press Release: Recursion Pharmaceuticals Secures $121 Million in Series C Financing". Salt Lake City, UT. 2019-07-15
Galapagos N.V.. (7/14/19). "Press Release: Gilead and Galapagos Enter into Transformative Research and Development Collaboration". Foster City, CA & Mechelen. 2019-07-14
Hookipa Pharma Inc.. (7/11/19). "Press Release: Hookipa Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers". New York, NY & Vienna. 2019-07-11
Agilent Technologies Inc.. (7/11/19). "Press Release: Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment". Santa Clara, CA. 2019-07-11
Novartis AG. (7/11/19). "Press Release: Novartis, Amgen and Banner Alzheimer's Institute Discontinue Clinical Program with BACE inhibitor CNP520 for Alzheimer's Prevention". Basel. 2019-07-11
ADC Therapeutics S.A.. (7/9/19). "Press Release: ADC Therapeutics Announces Final Close of Series E Financing Expansion". Lausanne. 2019-07-09
Revolution Medicines, Inc.. (7/9/19). "Press Release: Revolution Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers". Redwood City, CA. 2019-07-09
BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz. 2019-07-09
Blue Water Vaccinces, Inc.. (7/9/19). "Press Release: Blue Water Vaccines, Developing Universal Flu Vaccine, Completes $7m Financing Following Successful Preclinical Study". Cincinnati, OH & Oxford. 2019-07-09
Oxford Nanopore Technologies Ltd.. (7/8/19). "Press Release: Scale-up – Oxford Nanopore’s New High-tech Factory Comes Online". Oxford. 2019-07-08
Biophytis S.A.. (7/8/19). "Press Release: Biophytis Announces the Launch of its Public Offering on Nasdaq". Paris & Cambridge, MA. 2019-07-08
[iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com & Life-Sciences-Scandinavia.com". Bremen. 2019-07-08
Bruker Corporation. (7/8/19). "Press Release: Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC". Zurich. 2019-07-08
Immatics Biotechnologies GmbH. (7/8/19). "Press Release: Immatics Appoints Harpreet Singh as Chief Executive Officer". Tübingen & Houston, TX. 2019-07-08
IGM Biosciences, Inc.. (7/8/19). "Press Release: IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline". 2019-07-08
[iito] Business Intelligence. (7/7/19). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-USA.com will be announced in due time by [iito] Business Intelligence". 2019-07-07
Cobo Technologies ApS. (7/5/19). "Press Release: CRISPR Researchers to Benefit from Cobo Technologies and Sciex Partnership". Copenhagen. 2019-07-05
Evotec SE. (7/3/19). "Press Release: Evotec Completes Acquisition of Just Biotherapeutics". Hamburg. 2019-07-03
GlaxoSmithKline plc. (7/3/19). "Press Release: ViiV Healthcare Receives EU Marketing Authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection". London. 2019-07-03
Nosopharm S.A.S.. (7/3/19). "Press Release: Nosopharm and Evotec Enter into Collaboration to Accelerate Development of Novel Antibiotics". Lyon & Hamburg. 2019-07-03
Oncovita S.A.S.. (7/2/19). "Press Release: Oncovita Signs Exclusive Licensing Agreement with Institut Pasteur. Agreement Will Cover Development and Marketing of Oncolytic Virotherapies". Paris. 2019-07-02
Bayer AG. (7/2/19). "Press Release: Leo Pharma Completes the Acquisition of Bayer’s Prescription Dermatology Business". Ballerup & Leverkusen. 2019-07-02
Cancer Research UK. (7/2/19). "Press Release: Cancer Research UK Forms Collaboration with SV Health Investors to Accelerate Development of Cancer Medicines". 2019-07-02
X-Biotix Therapeutics, Inc.. (7/1/19). "Press Release: X-Biotix Therapeutics Joins Antimicrobials Working Group". Washington, DC. 2019-07-01
[iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. 2019-07-01
Bayer AG. (7/1/19). "Press Release: Century Therapeutics Launches with USD 250M Financing for induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform". Leverkusen, Philadelphia, PA & Tokyo. 2019-07-01
Illumina, Inc.. (6/28/19). "Press Release: Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US". San Diego, CA. 2019-06-28
Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London. 2019-06-28
Draper. (6/27/19). "Press Release: Draper Signs Collaboration Agreement with Bristol-Myers Squibb". 2019-06-27
Polyphor Ltd.. (6/27/19). "Press Release: Polyphor Appoints Frank Weber as New Chief Medical and Development Officer". Allschwil. 2019-06-27
Evotec SE. (6/26/19). "Press Release: Evotec SE Places First Schuldschein (Promissory Note) Worth EUR 250 m". Hamburg. 2019-06-26
ImmunoPrecise Antibodies Ltd.. (6/26/19). "Press Release: ImmunoPrecise Guarantees Success for Customers of Their Well-established B Cell Select Antibody Discovery Platform". Victoria, BC. 2019-06-26
Quanterix Corporation. (6/26/19). "Press Release: Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier". Billerica, MA. 2019-06-26
Zelluna Immunotherapy AS. (6/25/19). "Press Release: Zelluna Immunotherapy Appoints Jens-Peter Marschner as Chief Medical Officer". Oslo. 2019-06-25
Eurofins Scientific. (6/25/19). "Press Release: Eurofins Expands Its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.". Luxembourg. 2019-06-25
Illumina, Inc.. (6/25/19). "News: Chinese Collaboration to Develop Cancer Tests on Illumina System. AnchorDx to Focus on Early Cancer Detection and Clinical Management Panels". 2019-06-25
Genedata AG. (6/25/19). "Press Release: Genedata Expands Collaboration with AstraZeneca on Deep Learning for High-Content Image Analysis". Basel. 2019-06-25
Erytech Pharma. (6/24/19). "Press Release: Erytech Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility". Princeton, NJ, Cambridge, MA & Lyon. 2019-06-24
Genfit S.A.. (6/24/19). "Press Release: Genfit and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China". Lille & Cambridge, MA. 2019-06-24
GlaxoSmithKline plc. (6/24/19). "Press Release: U.S. Food and Drug Administration Accepts GSK’s Application for Zejula (niraparib) in Late Stage Ovarian Cancer with Priority Review". London. 2019-06-24
Gilead Sciences, Inc.. (6/24/19). "Press Release: Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies". Foster City, CA & Kobe. 2019-06-24
Erytech Pharma. (6/24/19). "Press Release: Erytech Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies". Lyon & Cambridge, MA. 2019-06-24
Eurofins Scientific. (6/24/19). "Press Release: Operations Returning to Normal After the Cyber Attack Announced on June 3, 2019". Luxembourg. 2019-06-24
MorphoSys AG. (6/24/19). "Press Release: MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer". Planegg. 2019-06-24
Arcus Biosciences, Inc.. (6/24/19). "Press Release: Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer". Hayward, CA. 2019-06-24
Illumina, Inc.. (6/21/19). "News: Driving Insights Through Microbiome Profiling. Metagenomic Shotgun Sequencing Workflow Enables Accurate DNA Detection From Soil". 2019-06-21
AB Sciex (d/b/a Sciex). (6/21/19). "Press Release: Sciex Announces Co-Marketing Agreement with EluciData to Break Down Barriers Faced by Metabolomics Researchers". Framingham, MA. 2019-06-21
Cambridge Innovation Capital plc. (6/21/19). "Press Release: Annual Results for the Year Ended 31 March 2019". 2019-06-21
Immunic, Inc.. (6/21/19). "Press Release: Immunic, Inc. Files Financial Statements and Pro Forma Financial Information in Accordance with Previously Completed Stock-for-Stock Exchange Transaction and Provides Corporate Update". San Diego, CA. 2019-06-21
Sanofi S.A.. (6/21/19). "Press Release: Sanofi and Regeneron Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma". Paris & Tarrytown, NY. 2019-06-21
Tangen Biosciences, inc.. (6/20/19). "Press Release: Tangen Biosciences Announces $9 Million Series A Financing to Accelerate Development of Disruptive Molecular Diagnostic Platform". Branford, CT. 2019-06-20
Hesperos, Inc.. (6/19/19). "Press Release: Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity to Enable Determination of Therapeutic Index". Orlando, FL. 2019-06-19
Catalent, Inc.. (6/19/19). "Press Release: Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy". New York, NY & Somerset, NJ. 2019-06-19
Lonza Group Ltd.. (6/19/19). "Press Release: Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel". Basel & Boston, MA. 2019-06-19
German Accelerator Life Sciences. (6/18/19). "Press Release: German Accelerator Appoints Marc Filerman as CEO Life Sciences". Munich & Cambridge, MA. 2019-06-18
Sanofi S.A.. (6/18/19). "Press Release: Sanofi and Google to Develop New Healthcare Innovation Lab". Paris. 2019-06-18
Pfizer Inc.. (6/17/19). "Press Release: Pfizer to Acquire Array BioPharma". New York, NY & Boulder, CO. 2019-06-17
Illumina, Inc.. (6/17/19). "Press Release: Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. 2019-06-17
GlaxoSmithKline plc. (6/13/19). "Press Release: GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery". London & San Francisco, CA. 2019-06-13
Spero Therapeutics, Inc.. (6/13/19). "Press Release: Spero Announces $10 Million Registered Direct Offering of Common Stock. Novo Holdings A/S through Its Novo REPAIR Impact Fund to Invest Up to $10 million". Cambridge, MA. 2019-06-13
Medicines Discovery Catapult, The. (6/12/19). "Press Release: Bringing the Benefits of Cutting-edge Mass Spectrometry Technologies to UK SMEs. Medicines Discovery Catapult and Waters Partner". 2019-06-12
ADC Therapeutics S.A.. (6/12/19). "Press Release: ADC Therapeutics Announces Completion of a Series E Financing Expansion. Brings Total Raised in the Series E Round to $276 Million". Lausanne. 2019-06-12
Ligand Pharmaceuticals Inc.. (6/12/19). "Press Release: Ligand Subsidiary Vernalis and PhoreMost Limited Announce Drug Discovery Collaboration for Novel Oncology". San Diego, CA & Cambridge. 2019-06-12
Dassault Systèmes S.A.. (6/12/19). "Press Release: Dassault Systèmes and Medidata Solutions to Join Forces to Accelerate the Life Sciences Industry Innovation for Patient-Centric Experience Through End-to-End Collaborative Platform". Vélizy-Villacoublay 2019-06-12
Genmab A/S. (6/11/19). "Press Release: Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody-CD38". Copenhagen. 2019-06-11
MaRS Innovation. (6/11/19). "Press Release: LAB150 Adds Project with Focus on Mental Health". Toronto, ON. 2019-06-11
Merck & Co., Inc.. (6/10/19). "Press Release: Merck to Acquire Tilos Therapeutics". Kenilworth, NJ. 2019-06-10
Sphere Fluidics Ltd.. (6/10/19). "Press Release: Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round". Cambridge. 2019-06-10
Evotec SE. (6/10/19). "Press Release: Evotec Receives $23.8m Grant to Join the Global Fight against Tuberculosis". Hamburg. 2019-06-10
Sanofi S.A.. (6/9/19). "Press Release: Soliqua Phase 3 Results Significantly Lowered Blood Sugar Levels Compared to GLP-1 Receptor Agonist Treatments". Paris. 2019-06-09
Sanofi S.A.. (6/7/19). "Press Release: Paul Hudson to Succeed Olivier Brandicourt as Chief Executive Officer". Paris. 2019-06-07
Kiadis Pharma N.V.. (6/6/19). "Press Release: Kiadis Pharma Completes Acquisition of CytoSen Therapeutics, Inc.". Amsterdam. 2019-06-06
Vertex Pharmaceuticals Inc.. (6/6/19). "Press Release: Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics". Boston, MA & Watertown, 2019-06-06
Third Rock Ventures, LLC. (6/6/19). "Press Release: Third Rock Ventures Raises $770 Million Fund V". Boston, MA. 2019-06-06
Evotec SE. (6/5/19). "Press Release: Evotec and Celgene further Expand iPSC Collaboration including New Cell Type". Hamburg. 2019-06-05
Schott AG. (6/5/19). "Press Release: Schott AG to Acquire Australian Microfluidic Expert MiniFAB". Melbourne & Mainz. 2019-06-05
InflaRx N.V.. (6/5/19). "Press Release: InflaRx Announces Top-Line SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa". Jena. 2019-06-05
Qiagen N.V.. (6/5/19). "Press Release: Qiagen and DiaSorin Collaborate on Novel QuantiFERON-based Test with Breakthrough Potential for Earlier Detection of Lyme Disease". Germantown, MD, Hilden & Saluggia. 2019-06-05
Curetis N.V.. (6/4/19). "Press Release: New Data on Curetis’ Unyvero LRT Panel for Pneumonia to be Presented at ASM Microbe 2019". Amsterdam, San Diego, CA & Holzgerlingen. 2019-06-04
Themis Bioscience GmbH. (6/4/19). "Press Release: CEPI Awards up to US$21 Million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development". Vienna & Oslo. 2019-06-04
Genedata AG. (6/4/19). "Press Release: Genedata Expressionist 13.0 Streamlines In-depth Characterization and Automates Quality Monitoring of Biopharmaceuticals". Atlanta, GA. 2019-06-04
Bluebird Bio, Inc.. (6/3/19). "Press Release: Bluebird Bio Announces EU Conditional Marketing Authorization for Zynteglo (autologous CD34+ cells encoding ßA-T87Q-globin gene) Gene Therapy". Cambridge, MA. 2019-06-03
Leo Pharma A/S. (6/3/19). "Press Release: Leo Pharma Appoints Catherine Mazzacco as New CEO". Ballerup. 2019-06-03
Sanofi S.A.. (6/2/19). "Press Release: Phase 3 Trial of Isatuximab Combination Therapy Showed 40% Reduction in the Risk of Disease Progression or Death for Patients with Relapsed/Refractory Multiple Myeloma". Paris. 2019-06-02
Biocartis Group N.V.. (6/1/19). "Press Release: Biocartis and Kite Sign Agreement for Development of Assays Supporting Kite's Therapies". Mechelen. 2019-06-01
Bruker Corporation. (5/31/19). "Press Release: Bruker Launches timsTOF fleX with ESI and MALDI for SpatialOMx". Atlanta, GA. 2019-05-31
University of Warwick. (5/31/19). "Press Release: Disruptive 2D Mass Spectrometry Spin-out Secures Seed Investment". 2019-05-31
Kiadis Pharma N.V.. (5/31/19). "Press Release: Kiadis Pharma Raises c.EUR 28 Million in a Private Placement of c.3.7 Million New Shares [Not for US, AU, CA, JP, ZA, et al.]". Amsterdam. 2019-05-31
Thrive Earlier Detection Corporation. (5/30/19). "Press Release: Thrive Launches with $110 Million Series A Financing to Integrate Earlier Detection of Multiple Cancer Types into Routine Medical Care". Cambridge, MA. 2019-05-30
Huntsworth plc. (5/30/19). "Press Release: Huntsworth plc Appoints Annabelle Sandeman as Its New Global Head of Commercial Strategy". London. 2019-05-30
[iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme 2019-05-30
Kiadis Pharma N.V.. (5/30/19). "Press Release: Kiadis Pharma Launches a Private Placement of New Shares to Raise approximately EUR 25 Million [Not for US, AU, CA, JP, ZA, et al.]". Amsterdam. 2019-05-30
Galapagos N.V.. (5/29/19). "Press Release: Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)". Foster City, CA & Mechelen. 2019-05-29
Kiadis Pharma N.V.. (5/29/19). "Press Release: Kiadis Pharma’s Extraordinary General Meeting of Shareholders Approves CytoSen Acquisition". Amsterdam. 2019-05-29
Vibalogics GmbH. (5/29/19). "Press Release: Ampersand Capital Partners to Acquire Vibalogics GmbH". Cuxhaven & Wellesley, MA. 2019-05-29
Foundation Medicine, Inc.. (5/29/19). "Press Release: Bayer and Foundation Medicine Announce Global Collaboration To Develop Next-generation Sequencing (NGS)-based Companion Diagnostics In Oncology". Cambridge, MA & Berlin. 2019-05-29
Nanobiotix S.A.. (5/28/19). "Press Release: Nanobiotix Announces the Launch of Curadigm. A New Nanotechnology Platform for Healthcare". Paris & Cambridge, MA. 2019-05-28
1 2 3 ... 119 120 121  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

» top